Establishing the Hepatitis B and C Prevention and Management Program: Malawi’s Experience

Conference on Liver Disease in Africa (COLDA) 2023

Prevalence and Risk Factors of Metabolic Dysfunction-Associated Fatty Liver disease (MAFLD) Among Adults with Chronic Hepatitis B Infection in The Gambia

Conference on Liver Disease in Africa (COLDA) 2023

Fatty Liver Disease and Its Correlates Among People Living with HIV Attending Care and Treatment Clinic at Temeke Regional Referral Hospital, Dar es Salaam, Tanzania

Conference on Liver Disease in Africa (COLDA) 2023

Non-Alcoholic Fatty Liver Disease in Tanzania: Prevalence, Determinants, and Correlation with Triglycerides-Glucose Index in Overweight and Obese Individuals

Conference on Liver Disease in Africa (COLDA) 2023

Bilharzia & Viral Hepatitis - Imam Waked, MD, FRCP, FAASLD

Conference on Liver Disease in Africa (COLDA) 2023

Compared to the Wild-type, the G1862T Mutant of Hepatitis B Virus (HBV) Induces Upregulation of Fibronectin Expression and Wnt/ β--catenin Pathway in Vitro

Conference on Liver Disease in Africa (COLDA) 2023

Molecular Characterization of Hepatitis B Virus Infection in HIV Infected Adults On Antiretroviral Therapy in Nairobi, Kenya

Conference on Liver Disease in Africa (COLDA) 2023

A New Player in the Management of Liver Disease in Sub-Saharan Africa: The Tanzania IR Experience - Erick Mbuguje, MD

Conference on Liver Disease in Africa (COLDA) 2023

Management of Complications of Cirrhosis - Eva Justine Uiso, MD, MMED, MSc

Conference on Liver Disease in Africa (COLDA) 2023

Introducing Sofosbuvir/Velpatasvir+Ribavirin as a Generic Retreatment Regimen for Hepatitis C: A Prospective Cohort Study in Rwanda

Conference on Liver Disease in Africa (COLDA) 2023

Virological Characterization of Treatment Failures and Retreatment Outcomes in People Living with “Unusual” HCV Genotype 1 Subtypes

Conference on Liver Disease in Africa (COLDA) 2023

HBeAg and HBV DNA in the Hepatitis B in Africa Collaborative Network (HEPSANET)

Conference on Liver Disease in Africa (COLDA) 2023

Effectiveness of Tenofovir Prophylaxis for the Prevention of Mother-To-Child- Transmission of Hepatitis B Virus in Burkina Faso

Conference on Liver Disease in Africa (COLDA) 2023

Evaluation of Interventions to Improve Timely Hepatitis B Birth Dose Vaccination Coverage Among Infants in Nigeria

Conference on Liver Disease in Africa (COLDA) 2023

Sustainable Access to Diagnostics & Therapeutics for HBV - John C. Rwegasha,MBChB, MMED, FRCP (Lond), MSc

Conference on Liver Disease in Africa (COLDA) 2023

HCV: Effect of Reinfection on Elimination - Importance of Self Testing - Janvier Serumondo, MD, MPH, MTM

Conference on Liver Disease in Africa (COLDA) 2023

Hepatitis E Virus Detected in Wastewater Samples in South Africa

Conference on Liver Disease in Africa (COLDA) 2023

Time to Initiation of Hepatitis B Treatment Is Reduced with the Use of the Xpert HBV DNA Kit

Conference on Liver Disease in Africa (COLDA) 2023

A Hepatitis B Virus Dual Point-of-Care Test Strategy to Identify Treatment-Eligible Patients in Africa

Conference on Liver Disease in Africa (COLDA) 2023

Hepatitis B (HBV) Testing and Treatment Policy Assessment in Six African Countries: Examples to Inform HBV Program Scale-Up

Conference on Liver Disease in Africa (COLDA) 2023

Hepatitis B Virus Genotypes - Anna Kramvis, BSc Hons, PhD

Conference on Liver Disease in Africa (COLDA) 2023

Barriers to Implementation/Access to Care - Danjuma K. Adda, MPH, FIMS, Dip-IMS

Conference on Liver Disease in Africa (COLDA) 2023

WHO HBV Guidelines - New Directions for Hepatitis B Treatment and Care and Implications for Africa - Philippa Easterbrook, MD, FRCP, MPH, DTM&H

Conference on Liver Disease in Africa (COLDA) 2023

African CDC - Growing Portfolio of Hepatitis-Related Activities - Hanna Amanuel Tesfahunei, MSc

Conference on Liver Disease in Africa (COLDA) 2023